Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 204.77
+6.17 (3.11%)
Jun 19, 2026, 3:30 PM IST
Hikal Revenue
In the fiscal year ending March 31, 2026, Hikal had annual revenue of 17.13B INR, down -7.91%. Hikal had revenue of 5.19B in the quarter ending March 31, 2026, a decrease of -5.97%.
Revenue
17.13B
Revenue Growth
-7.91%
P/S Ratio
1.48
Revenue / Employee
8.31M
Employees
2,062
Market Cap
25.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 17.13B | -1.47B | -7.91% |
| Mar 31, 2025 | 18.60B | 752.00M | 4.21% |
| Mar 31, 2024 | 17.85B | -2.38B | -11.79% |
| Mar 31, 2023 | 20.23B | 803.09M | 4.13% |
| Mar 31, 2022 | 19.43B | 2.22B | 12.92% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.45B |
| Aarti Pharmalabs | 18.19B |
| Innova Captab | 16.30B |
| Solara Active Pharma Sciences | 13.69B |
| Windlas Biotech | 9.04B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 7.08B |
| Ind-Swift Laboratories | 6.41B |
Hikal News
- 22 days ago - Hikal shares fall over 7% as Q4 net profit drops 71% YoY to Rs 14.4 crore, EBITDA down 14.6% - Business Upturn
- 23 days ago - Hikal reports Q4 FY26 revenue of Rs 519 crore with 20.3% EBITDA margin - Business Upturn
- 23 days ago - Hikal Q4 Results: Net profit falls 71% YoY to Rs 14.4 crore, revenue down 6% - Business Upturn
- 2 months ago - Pharma sector stocks surge sharply today, April 8: Sudeep Pharma rally 9.41%, KIMS up 5.52%, HIKAL jumps 5.30% - Business Upturn
- 4 months ago - Pharma sector stocsk today, Feb 12: Hikal jumps 13.46%, Zydus up 2.44%, Biocon rises 2.31% - Business Upturn
- 4 months ago - Hikal shares rally sharply over 10% on solid Q3 results - Business Upturn
- 7 months ago - Hikal shares rally over 12% today; Details here - Business Upturn
- 7 months ago - Hikal shares fall over 5% as company reports Q2 net loss and nearly 30% drop in sales - Business Upturn